Mark C. Schneyer
EVP, CHIEF FINANCIAL OFFICER · 3 filings · Latest: May 1, 2026
ACADIA PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 4, 2026 | Sale | $21.79 | 3,506 | $76.4K | 66,145 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 1, 2026 | Option Exercise | — | 6,815 | — | 69,651 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 7, 2026 | Sale | $22.20 | 2,709 | $60.1K | 62,836 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 5, 2026 | Option Exercise | — | 5,276 | — | 65,545 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 26, 2026 | Sale | $21.65 | 3,208 | $69.5K | 60,269 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 25, 2026 | Option Exercise | — | 6,178 | — | 63,477 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 25, 2026 | Sale | $21.47 | 4,177 | $89.7K | 57,299 | |
ACAD | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 24, 2026 | Option Exercise | — | 8,138 | — | 61,476 |